Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BARD C R INC /NJ/BCR · Entity 170698 | Director | December 29, 2017 | January 03, 2018 |
| Carlyle Group Inc.CG · Entity 3316 | Director | May 01, 2026 | May 01, 2026 |
| GILEAD SCIENCES, INC.GILD · Entity 405 | Director | August 26, 2026 | August 27, 2026 |
| LOEWS CORPL · Entity 3231 | Director | March 03, 2025 | March 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BARD C R INC /NJ/
Report date December 29, 2017 · Filed January 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 1
1 source rowRow 1 · 2017-12-29 · Disposition to issuer · Disposed 4,520 · Balance 0 F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 20,596.9 |
Reported balance
After 2017-12-29 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-12-29 · Grant · Acquired 83.42 · Balance 20,596.9 F2: Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees. F3: Conversion is 1 for 1. F4: Phantom stock units are settled in cash upon termination of service as director. F5: Includes 32.86 units for dividend credits. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-12-29 · Disposition to issuer · Disposed 20,596.9 · Balance 0 F2: Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees. F3: Conversion is 1 for 1. F6: These units, which are 100% vested, were paid out in cash in accordance with the Merger Agreement. |
| Share Equivalent UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-12-29 · Disposition to issuer · Disposed 17,808 · Balance 0 F7: Units granted under the Company's Stock Equivalent Plan for Outside Directors. F3: Conversion is 1 for 1. F8: These units, which are 100% vested, were assumed by BD at the effective time of the Merger. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration").
F2: Units are credited under the Company's Deferred Compensation Contract, Deferral of Directors' Fees.
F3: Conversion is 1 for 1.
F4: Phantom stock units are settled in cash upon termination of service as director.
F5: Includes 32.86 units for dividend credits.
F6: These units, which are 100% vested, were paid out in cash in accordance with the Merger Agreement.
F7: Units granted under the Company's Stock Equivalent Plan for Outside Directors.
F8: These units, which are 100% vested, were assumed by BD at the effective time of the Merger.
Carlyle Group Inc.
Report date May 01, 2026 · Filed May 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 47,849 |
Reported balance
After 2026-05-01 transaction · row 1
1 source rowRow 1 · 2026-05-01 · Grant · Acquired 4,450 · Balance 47,849 F1: These securities are a restricted stock unit award granted under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan. These securities will vest on May 1, 2027, subject to the reporting person's continued service on the Issuer's Board of Directors on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are a restricted stock unit award granted under The Carlyle Group Inc. Amended & Restated 2012 Equity Incentive Plan. These securities will vest on May 1, 2027, subject to the reporting person's continued service on the Issuer's Board of Directors on such vesting date.
GILEAD SCIENCES, INC.
Report date August 26, 2026 · Filed August 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,894 |
Ending reported balance
After 2026-08-26 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2026-08-26 · Exercise / conversion · Acquired 7,718 · Balance 20,612 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. Row 2 · 2026-08-26 · Sale · Disposed 3,118 · Balance 17,494 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F2: Sale prices for the transactions reported range from $147.58 to $148.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Row 3 · 2026-08-26 · Sale · Disposed 4,600 · Balance 12,894 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F3: Sale prices for the transactions reported range from $148.58 to $149.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Row 4 · 2026-08-26 · Exercise / conversion · Acquired 10,282 · Balance 23,176 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. Row 5 · 2026-08-26 · Sale · Disposed 3,402 · Balance 19,774 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F4: Sale prices for the transactions reported range from $147.57 to $148.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Row 6 · 2026-08-26 · Sale · Disposed 6,880 · Balance 12,894 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F5: Sale prices for the transactions reported range from $148.57 to $149.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.67 · Expires 2030-10-22 | Direct | 0 |
Reported balance
After 2026-08-26 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-08-26 · Exercise / conversion · Disposed 7,718 · Balance 0 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F6: 100% of the shares subject to the stock option vested immediately upon the grant date of October 22, 2020. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.35 · Expires 2032-05-05 | Direct | 5,569 |
Reported balance
After 2026-08-26 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-08-26 · Exercise / conversion · Disposed 10,282 · Balance 5,569 F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026. F7: 25% of the shares subject to the option vested on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option were fully vested and exercisable on October 22, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2026.
F2: Sale prices for the transactions reported range from $147.58 to $148.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F3: Sale prices for the transactions reported range from $148.58 to $149.5799. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F4: Sale prices for the transactions reported range from $147.57 to $148.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F5: Sale prices for the transactions reported range from $148.57 to $149.5699. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request.
F6: 100% of the shares subject to the stock option vested immediately upon the grant date of October 22, 2020.
F7: 25% of the shares subject to the option vested on each three-month anniversary measured from October 22, 2020 such that 100% of the shares subject to the option were fully vested and exercisable on October 22, 2021.
LOEWS CORP
Report date March 03, 2025 · Filed March 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 9,845 |
Ending reported balance
After 2025-03-03 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-03-03 · Exercise / conversion · Acquired 2,250 · Balance 12,095 F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024. Row 2 · 2025-03-03 · Disposition to issuer · Disposed 1,053 · Balance 11,042 F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024. Row 3 · 2025-03-03 · Sale · Disposed 1,197 · Balance 9,845 F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024. |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $40.61 · Expires 2025-03-31 | Direct | 0 |
Reported balance
After 2025-03-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-03-03 · Exercise / conversion · Disposed 2,250 · Balance 0 F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024. F2: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost. |
Filing footnotes · ownership attribution and instrument terms
F1: The transactions reported in this Form 4 were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024.
F2: The Reporting Person received the Derivative Security pursuant to a stock appreciation right grant at no cost.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
UNITEDHEALTH GROUP INC
Report date June 05, 2012 · Filed June 07, 2012
Section 16 reporting ended · disclosed 2012-06-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 119,908.836 |
Reported balance
After 2012-06-05 transaction · row 1
1 source rowRow 1 · 2012-06-05 · Tax withholding · Disposed 7,211 · Balance 119,908.836 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 13, 2011 Filed Dec 15, 2011 22:35 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 51,562 | $29.74 | $1,533,453.88 |
DisclosureSEC source: 0001209191-11-061540 · doc4.xml · nonDerivative · entry 3 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,058.281 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2011 Filed Dec 15, 2011 22:35 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 33,160 | $48.20 | $1,598,312.00 |
DisclosureSEC source: 0001209191-11-061540 · doc4.xml · nonDerivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,496.281 Read SEC document |
| December 13, 2011 Filed Dec 15, 2011 22:35 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 40,000 | $33.94 | $1,357,600.00 |
DisclosureSEC source: 0001209191-11-061540 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,656.281 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 21, 2011 Filed Sep 22, 2011 22:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 182.113 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-048799 · doc4.xml · nonDerivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,656.281 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| July 26, 2011 Filed Jul 27, 2011 20:40 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | SaleCommon Stock | 1,225 | $51.49 | $63,077.95 |
DisclosureSEC source: 0001209191-11-041130 · doc4.xml · nonDerivative · entry 4 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,307.256 F3 · price: This transaction was executed in multiple trades ranging from $51.49 to $51.494 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| July 25, 2011 Filed Jul 27, 2011 20:40 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionStock Appreciation Right · Derivative | 5,000 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0001209191-11-041130 · doc4.xml · derivative · entry 5 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,122 Underlying: Common Stock · 5,000 shares Expires 2019-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Read SEC document |
| July 25, 2011 Filed Jul 27, 2011 20:40 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 3,775 | $51.63 | $194,903.25 |
DisclosureSEC source: 0001209191-11-041130 · doc4.xml · nonDerivative · entry 3 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,532.256 F2 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| July 25, 2011 Filed Jul 27, 2011 20:40 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 5,000 | $29.74 | $148,700.00 |
DisclosureSEC source: 0001209191-11-041130 · doc4.xml · nonDerivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,307.256 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| July 25, 2011 Filed Jul 27, 2011 20:40 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | SaleCommon Stock | 19,800 | $52.03 | $1,030,124.70 |
DisclosureSEC source: 0001209191-11-041130 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,307.256 F1 · price: This transaction was executed in multiple trades ranging from $52.00 to $52.10 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F2 · balance_after: Includes shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| June 21, 2011 Filed Sep 22, 2011 22:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 166.912 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-048799 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,474.168 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| June 05, 2011 Filed Jun 7, 2011 21:34 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 7,211 | $48.85 | $352,257.35 |
DisclosureSEC source: 0001209191-11-033558 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,455.79 Read SEC document |
| March 21, 2011 Filed Mar 22, 2011 22:37 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 154.79 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-019271 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,666.79 F1 · shares: Represents payment of dividend equivalents on outstanding restricted stock units. The dividend equivalents are subject to the same terms as the underlying restricted stock units and are forfeited if the related award does not vest. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 53,483 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-11-008874 · doc4.xml · nonDerivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,512 F1 · shares: The restricted stock units will vest at a rate of 33% on February 9, 2012; December 28, 2012; and February 9, 2014. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2011, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 53,483. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:31 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 2,100 | $42.07 | $88,347.00 |
DisclosureSEC source: 0001209191-11-008874 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP, UnitedHealth Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,029 Read SEC document |
| February 03, 2011 Filed Feb 4, 2011 23:56 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 2,738 | $43.04 | $117,843.52 |
DisclosureSEC source: 0001209191-11-007325 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Public & Sr Mkt Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,129 Read SEC document |
| December 14, 2010 Filed Dec 15, 2010 22:27 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 1,460 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-060707 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Public & Sr Mkt Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,867 F1 · shares: Represents the cancellation of shares for the payment of a FICA tax liability. Read SEC document |
| December 09, 2010 Filed Dec 10, 2010 21:22 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 97,500 | $0.00 Strike: $28.10 | $0.00 |
DisclosureSEC source: 0001209191-10-059642 · doc4.xml · derivative · entry 5 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Public & Sr Mkt Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 97,500 shares Expires 2013-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The stock options vested at a rate of 33 1/3% annually on October 28 from the years 2005 through 2007. Read SEC document |
| December 09, 2010 Filed Dec 10, 2010 21:22 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | SaleCommon Stock | 97,500 | $36.51 | $3,559,588.50 |
DisclosureSEC source: 0001209191-10-059642 · doc4.xml · nonDerivative · entry 4 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Public & Sr Mkt Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,327 F2 · price: This transaction was executed in multiple trades ranging from $36.46 to $36.565 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. F1 · balance_after: Includes shares and dividend shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| December 09, 2010 Filed Dec 10, 2010 21:22 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Exercise / conversionCommon Stock | 97,500 | $28.10 | $2,739,750.00 |
DisclosureSEC source: 0001209191-10-059642 · doc4.xml · nonDerivative · entry 3 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Public & Sr Mkt Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,827 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares and dividend shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| December 09, 2010 Filed Dec 10, 2010 21:22 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GiftCommon Stock | 5,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-059642 · doc4.xml · nonDerivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Public & Sr Mkt Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,327 F1 · balance_after: Includes shares and dividend shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| December 08, 2010 Filed Dec 10, 2010 21:22 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GiftCommon Stock | 26,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-10-059642 · doc4.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Public & Sr Mkt Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,977 F1 · balance_after: Includes shares and dividend shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| June 05, 2010 Filed Jun 8, 2010 21:35 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 7,210 | $30.34 | $218,751.40 |
DisclosureSEC source: 0000731766-10-000077 · edgardoc.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,408 F1 · balance_after: Includes dividend shares received through UnitedHealth Group Incorporated's Employee Stock Purchase Plan. Read SEC document |
| February 09, 2010 Filed Feb 11, 2010 23:51 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantStock Appreciation Rights · Derivative | 76,024 | $0.00 Strike: $33.00 | $0.00 |
DisclosureSEC source: 0000731766-10-000034 · edgardoc.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,024 Underlying: Common Stock · 76,024 shares Expires 2020-02-09 F3 · derivative.exercise_date: The stock appreciation rights will vest at a rate of 25% annually on February 9 from the years 2011 through 2014. Read SEC document |
| February 09, 2010 Filed Feb 11, 2010 23:51 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 30,304 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-10-000034 · edgardoc.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,613 F1 · shares: The restricted stock units will vest at a rate of 25% annually on February 9 from the years 2011 through 2014. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 9, 2010, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of cumulative 3-year EPS and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 60,607. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| February 03, 2010 Filed Feb 5, 2010 23:24 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 3,099 | $33.32 | $103,258.68 |
DisclosureSEC source: 0000731766-10-000019 · edgardoc.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,309 F1 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| June 05, 2009 Filed Jun 8, 2009 21:20 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | Tax withholdingCommon Stock | 7,210 | $27.10 | $195,391.00 |
DisclosureSEC source: 0000731766-09-000064 · edgardoc.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,502 F1 · balance_after: Includes dividend shares received through UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| February 23, 2009 Filed Feb 26, 2009 02:46 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantStock Appreciation Rights · Derivative | 113,122 | $0.00 Strike: $29.74 | $0.00 |
DisclosureSEC source: 0000731766-09-000038 · edgardoc.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,122 Underlying: Common Stock · 113,122 shares Expires 2019-02-23 F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on February 3 from the years 2010 through 2013. Read SEC document |
| February 23, 2009 Filed Feb 26, 2009 02:46 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 38,462 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-09-000038 · edgardoc.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,707 F1 · security: The restricted stock units will vest at a rate of 25% annually on February 3 from the years 2010 through 2013. F2 · balance_after: Amount does not include performance-based restricted stock units granted to the executive officer on February 23, 2009, as performance awards not tied to stock price are not derivative securities for purposes of Section 16 under guidance from the staff of the SEC. The number of performance-based restricted stock units that the executive officer will receive will be determined at the end of the 3-year performance period and will be dependent upon the achievement of average EPS growth percentanges and average return-on-equity performance metrics approved by the Compensation and Human Resources Committee. The target number of performance-based restricted stock units is 76,923. Amount does include shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
| June 05, 2008 Filed Jun 9, 2008 23:15 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantStock Appreciation Rights · Derivative | 84,851 | $0.00 Strike: $33.94 | $0.00 |
DisclosureSEC source: 0000731766-08-000098 · edgardoc.xml · derivative · entry 2 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,851 Underlying: Common Stock · 84,851 shares Expires 2018-06-05 F3 · derivative.exercise_date: The stock appreciation rights vest at a rate of 25% annually on June 5 from the years 2009 through 2012. Read SEC document |
| June 05, 2008 Filed Jun 9, 2008 23:15 UTC | UNITEDHEALTH GROUP INC UNH · Entity 2809 | GrantCommon Stock | 68,348 | $0.00 | $0.00 |
DisclosureSEC source: 0000731766-08-000098 · edgardoc.xml · nonDerivative · entry 1 WELTERS ANTHONY · CIK 0001213307 · EVP & Pres Publc & Sr Mkts Grp 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,803 F1 · security: The restricted stock units will vest at a rate of 25% annually on June 5 from the years 2009 through 2012. F2 · balance_after: Includes shares acquired under UnitedHealth Group's Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.